Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 21, 2022
Alliance Pharma hired four new leaders, bringing on a new Chief Operating Officer (COO), Chief Commercial Officer (CCO), Chief Financial Officer (CFO), and Chief People Officer (CPO). These leaders will support continued global expansion, which ...
read more
Wednesday, September 21, 2022
Accumulus Synergy, a non-profit organization working to develop an information and data exchange platform aimed at transforming how life science innovators and health authorities worldwide interact, announced that Merck, known as MSD outside the ...
read more
Wednesday, September 21, 2022
WuXi Biologics announced that its two Drug Substance (DS) facilities and a Drug Product (DP) facility located in Wuxi city received regulatory approvals from the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA).
read more
Wednesday, September 21, 2022
Lykan Bioscience named Barbara Ressler, Ph.D. VP of Manufacturing Process Sciences. development, process development and manufacturing science and technology (MS&T) teams.
read more
Wednesday, September 21, 2022
Merck will initiate a new Phase 3 clinical program with once-daily islatravir for the treatment of people with HIV-1 infection.
read more
Thursday, September 22, 2022
Bora Pharmaceutical Labs, a division of Bora Pharmaceuticals, partnered with TaiRx, a Taiwanese drug development company, to manufacture a novel anticancer drug, CVM-1118.
read more
Thursday, September 22, 2022
Peli BioThermal extends service centers in Japan with a new facility, situated near Tokyo’s international Narita Airport.
read more
Thursday, September 22, 2022
Catalent, a leader in enabling biopharma, cell, gene, and consumer health partners to optimize the development, launch, and supply of better patient treatments across multiple modalities, announced that it has reached an agreement to acquire Metrics ...
read more
Thursday, September 22, 2022
Kaléo announced the execution of the first contract with the U.S. Department of Defense (DoD) for the procurement of the Rapid Opioid Countermeasure System (ROCS), a 10 mg Naloxone Auto-injector (naloxone hydrochloride injection) antidote for ultra-...
read more
Thursday, September 22, 2022
AbCellera launched the second phase of its global headquarters expansion by breaking ground on its new facility in Vancouver, Canada.
read more
Quotient Sciences, a drug development and manufacturing accelerator, completed major investments and expansions at its Nottingham, UK and Reading, UK, facilities to support the delivery of fully integrated drug development programs through the ...
read more
Samsung Biologics, a world-leading contract development and manufacturing organization (CDMO), is launching its new proprietary development technology platforms – S-DUAL™ and DEVELOPICK™ – at this year's BioProcess International Conference and ...
read more
The Almac Group announced the appointment of Graeme McBurney to the Board of Directors in the role of Chief Operating Officer effective 1st October 2022.
read more
Wednesday, October 05, 2022
Almac Clinical Services announced a new state-of-the-art Cryogenic Service Solution within its Durham, North Carolina campus to support cell and gene therapies.
read more
Wednesday, October 05, 2022
Ginkgo Bioworks made a tuck-in acquisition of Circularis, a biotechnology company with a proprietary circular RNA and promoter screening platform.
read more